INVIVIS PHARMACEUTICALS INC has a total of 16 patent applications. Its first patent ever was published in 2012. It filed its patents most often in New Zealand, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, measurement and biotechnology are HUMANWELL PURACAP PHARMACEUTICALS WUHAN CO LTD, GUANGZHOU BAIYUNSHAN HUTCHISON WHAMPOA CHINESE MEDICINE CO LTD and GUANGZHOU BAIYUNSHAN QIXING PHARMACEUTICAL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | New Zealand | 2 | |
#2 | United States | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Australia | 1 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | China | 1 | |
#8 | EPO (European Patent Office) | 1 | |
#9 | Hong Kong | 1 | |
#10 | Israel | 1 | |
#11 | Republic of Korea | 1 | |
#12 | Mexico | 1 | |
#13 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Therapeutic chemical compounds | |
#3 | Measuring microorganism processes | |
#4 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Gilles Erard | 13 |
#2 | Erard Gilles | 2 |
Publication | Filing date | Title |
---|---|---|
WO2014152640A1 | Assay for predictive biomarkers of anti-androgen efficacy | |
CA2854555A1 | Assay for predictive biomarkers of anti-estrogen efficacy | |
NZ717890A | Methods and systems for identifying and treating anti-progestin sensitive tumors |